Literature DB >> 14756273

Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma.

Shawn D St Peter1, Adyr A Moss, Eric A Huettl, Kevin O Leslie, David C Mulligan.   

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare liver tumor with an indolent course relative to other hepatic malignancies. Over the past two decades, primary treatment for these lesions has been defined as resection for localized disease, or transplantation for diffuse and multifocal tumors. No published report to date has described effective pre- or post-operative adjuvant treatment for this disease. In this report, we present the first case of HEHE effectively managed with chemoembolization followed by transplantation, documenting objective tumor response to embolization. Furthermore, diagnosis for this lesion can easily be mistaken, directing management in erroneous directions. This case illustrates diagnostic pitfalls affiliated with the work-up of this tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14756273     DOI: 10.1046/j.1399-0012.2003.00055.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  8 in total

1.  [Malignant epithelioid hemangioendothelioma of the liver. Results of surgical treatment strategies].

Authors:  J M Langrehr; I Petersen; R Pfitzmann; E Lopez-Hänninen
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

2.  Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005.

Authors:  Joel A Rodriguez; Natasha S Becker; Christine A O'Mahony; John A Goss; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

3.  Living donor liver transplantation for epithelioid hemangioendothelioma: Report of a case.

Authors:  Kiyoshi Hasegawa; Yasuhiko Sugawara; Mami Ikeda; Takeaki Ishizawa; Kenichi Ohashi; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.

Authors:  Ryan M Thomas; Thomas A Aloia; Mark J Truty; Warren H Tseng; Eugene A Choi; Steven A Curley; Jean N Vauthey; Eddie K Abdalla
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

Review 5.  Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations.

Authors:  Peter Gunvén
Journal:  Med Oncol       Date:  2007-08-03       Impact factor: 3.064

6.  Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience.

Authors:  Linping Cao; Jiawei Hong; Lingfeng Zhou; Yufu Ye; Yuanxing Liu; Jun Yu; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2019-11-07       Impact factor: 2.754

7.  Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis.

Authors:  Xiaolei Liu; Zihuan Zhang; Jia Huang; Haidong Tan; Zhiying Yang
Journal:  Cancer Manag Res       Date:  2021-11-03       Impact factor: 3.989

Review 8.  Hepatic Hemangioendothelioma: An update.

Authors:  Mayur Virarkar; Mohammed Saleh; Radwan Diab; Melissa Taggart; Peeyush Bhargava; Priya Bhosale
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.